• SPX
  • $5,953.01
  • 0.07 %
  • $4.30
  • DJI
  • $44,127.71
  • 0.59 %
  • $257.35
  • N225
  • $38,283.85
  • 0.68 %
  • $257.68
  • FTSE
  • $8,266.48
  • 1.44 %
  • $117.21
  • IXIC
  • $18,927.15
  • -0.24 %
  • -$45.27
Design Therapeutics, Inc. (DSGN) Ownership

Design Therapeutics, Inc. (DSGN) Ownership

NASDAQ Currency in USD Disclaimer

Stock Price

$5.65

$0.08

(1.44%)

Day's range
$5.5
Day's range
$5.72
Recent Quarter Total Invested

$353.91 M

$137.58 M
Recent Quarter Institutional Ownership Percentage

116.18%

-$1.51
Total Invested of Last Quarter

$216.33 M

Ownership Percentage of Last Quarter

117.69%

Design Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
PRICE T ROWE ASSOCIATES INC /MD/ 11/14/2024 7.56 M $778.79 M   3.77% 13.36%
DURABLE CAPITAL PARTNERS LP 11/14/2024 3.46 M $355.82 M   0.00% 6.10%
CONESTOGA CAPITAL ADVISORS, LLC 10/28/2024 3.17 M $326.24 M   1.68% 5.60%
JARISLOWSKY, FRASER LTD 11/13/2024 2.84 M $292.45 M   -1.78% 5.01%
FIERA CAPITAL CORP 11/01/2024 2.58 M $265.69 M   0.77% 4.55%
MACKENZIE FINANCIAL CORP 11/13/2024 2.15 M $220.95 M   0.61% 3.79%
PRIMECAP MANAGEMENT CO/CA/ 11/08/2024 2.11 M $217.70 M   -5.55% 3.73%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 11/08/2024 1.91 M $196.77 M   -6.75% 3.38%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 11/14/2024 1.67 M $171.49 M   -1.86% 2.94%
BANK OF MONTREAL /CAN/ 11/13/2024 1.53 M $156.34 M   -0.81% 2.71%
GENEVA CAPITAL MANAGEMENT LLC 11/05/2024 1.48 M $152.04 M   1.30% 2.61%
FRANKLIN RESOURCES INC 11/12/2024 1.37 M $142.69 M   3.07% 2.42%
INVESCO LTD. 11/12/2024 1.35 M $139.08 M   -4.12% 2.39%
CONGRESS ASSET MANAGEMENT CO /MA 10/28/2024 1.21 M $124.77 M   -0.80% 2.14%
TD ASSET MANAGEMENT INC 11/01/2024 871,558 $89.17 M   10.01% 1.54%
RIVERBRIDGE PARTNERS LLC 10/15/2024 866,193 $89.18 M   -4.91% 1.53%
BLACKROCK FUNDING, INC. /DE 11/13/2024 705,663 $72.66 M   100.00% 1.25%
NATIONAL BANK OF CANADA /FI/ 11/15/2024 699,157 $71.91 M   389.78% 1.23%
LORD, ABBETT & CO. LLC 11/14/2024 672,897 $69.28 M   12.08% 1.19%
ROYAL BANK OF CANADA 11/14/2024 641,327 $66.03 M   -6.96% 1.13%
JANUS HENDERSON GROUP PLC 11/14/2024 632,168 $65.12 M   -0.21% 1.12%
GW&K INVESTMENT MANAGEMENT, LLC 11/07/2024 613,952 $63.21 M   -8.13% 1.08%
WESTFIELD CAPITAL MANAGEMENT CO LP 11/12/2024 585,163 $60.25 M   3.58% 1.03%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 11/13/2024 584,830 $60.22 M   0.10% 1.03%
ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC 10/18/2024 562,926 $57.96 M   -5.22% 0.99%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 11/14/2024 559,529 $57.58 M   -8.55% 0.99%
AMERIPRISE FINANCIAL INC 11/14/2024 488,896 $59.19 M   0.05% 0.86%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2024 479,681 $50.28 M   10.74% 0.85%
BAIRD FINANCIAL GROUP, INC. 11/14/2024 471,810 $48.58 M   -11.34% 0.83%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 11/12/2024 470,631 $48.46 M   2.12% 0.83%
BANK OF NOVA SCOTIA 11/13/2024 454,177 $46.74 M   0.16% 0.80%
SEGALL BRYANT & HAMILL, LLC 11/08/2024 438,553 $45.15 M   1.30% 0.77%
CLEARBRIDGE INVESTMENTS, LLC 11/12/2024 424,022 $43.66 M   -1.09% 0.75%
PREMIER FUND MANAGERS LTD 11/08/2024 411,419 $42.04 M   0.00% 0.73%
LEGAL & GENERAL GROUP PLC 11/14/2024 402,676 $41.48 M   -14.35% 0.71%
NEUBERGER BERMAN GROUP LLC 11/14/2024 399,043 $41.09 M   1.94% 0.70%
RENAISSANCE TECHNOLOGIES LLC 11/13/2024 369,700 $38.06 M   0.96% 0.65%
ARTISAN PARTNERS LIMITED PARTNERSHIP 11/12/2024 362,135 $37.26 M   -19.55% 0.64%
MORGAN STANLEY 11/14/2024 357,173 $36.77 M   26.06% 0.63%
1832 ASSET MANAGEMENT L.P. 11/13/2024 316,594 $32.60 M   34.00% 0.56%
BLAIR WILLIAM & CO/IL 11/12/2024 314,398 $32.37 M   -11.17% 0.56%
MACQUARIE GROUP LTD 11/14/2024 310,333 $31.95 M   -2.44% 0.55%
WASATCH ADVISORS LP 11/14/2024 305,228 $31.40 M   -24.61% 0.54%
DF DENT & CO INC 11/15/2024 279,675 $28.80 M   27.94% 0.49%
MILLENNIUM MANAGEMENT LLC 11/14/2024 272,426 $28.04 M   175.77% 0.48%
PRINCIPAL FINANCIAL GROUP INC 10/31/2024 270,833 $27.90 M   -1.19% 0.48%
ZENO EQUITY PARTNERS LLP 11/12/2024 266,968 $27.49 M   0.26% 0.47%
SWISS NATIONAL BANK 11/07/2024 258,324 $26.62 M   1.06% 0.46%
RUSSELL INVESTMENTS GROUP, LTD. 11/13/2024 255,597 $26.32 M   -1.36% 0.45%
ALLIANCEBERNSTEIN L.P. 11/14/2024 250,592 $25.80 M   -2.21% 0.44%

Design Therapeutics, Inc.institutional Ownership - Frequently Asked Questions

  • Who are the largest shareholders of DSGN shares?

    During the previous two years, 385 institutional investors and hedge funds held shares of Design Therapeutics, Inc.. The most heavily invested institutionals were:

    PRICE T ROWE ASSOCIATES INC /MD/: 7.56 M

    Durable Capital Partners LP: 3.46 M

    Conestoga Capital Advisors, LLC: 3.17 M

    Jarislowsky, Fraser Ltd: 2.84 M

    Fiera Capital Corp: 2.58 M

    MACKENZIE FINANCIAL CORP: 2.15 M

  • What percentage of Design Therapeutics, Inc. stock is owned by institutional investors?

    116.18% of Design Therapeutics, Inc. stock is owned by institutional investors.

  • How much institutional buying is happening at DSGN ?

    Institutional investors have bought a total of 68.90 M shares in the last 24 months. This purchase volume represents approximately $389.28 M in transactions.

×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.